Intrabone Cord Blood Transplantation
The purpose of this study is to evaluate the viability of intrabone administration of umbilical cord blood as allogenic transplantation for the treatment of hematologic malignancies.
Hematological Malignancies
PROCEDURE: Intrabone administration of umbilical cord blood
Kinetics of hematopoietic engraftment, days 14, 21, 28 after administration
Dynamics and chimerism of hematological engraftment, days 14, 21, 28 after administration
The purpose of this study is to evaluate the viability of intrabone administration of umbilical cord blood as allogenic transplantation for the treatment of hematologic malignancies.